Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children

Lotte Rasmussen*, Nicole Pratt, Elizabeth Roughead, Anna Moffat

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Based on data from the Longitudinal Study of Australian Children linked with pharmacy dispensing data from the Australian Government’s Pharmaceutical Benefits Scheme, we calculated the 1-year prevalence of psychotropic medicine supply in children and adolescents with Autism Spectrum Disorder (ASD) as reported by parents in 2014. The majority of children and adolescents with ASD in Australia were not treated with psychotropic medicine. One-third had claims for at least one psychotropic medication, most commonly medications for attention-deficit/hyperactivity disorder (ADHD), and antidepressants. Antipsychotics were supplied to less than one in twenty children and approximately one in ten adolescents. In line with findings from North America, psychotropic medicine was more often supplied to children and adolescents with ASD and comorbid ADHD.

OriginalsprogEngelsk
TidsskriftJournal of Autism and Developmental Disorders
Vol/bind49
Udgave nummer1
Sider (fra-til)227–235
ISSN0162-3257
DOI
StatusUdgivet - jan. 2019

Fingeraftryk

Drug Utilization
Longitudinal Studies
Medicine
North America
Parents
Autism Spectrum Disorder
Pharmaceutical Preparations

Citer dette

@article{97c0fd83b64949b4a7fa9fef6a78eeba,
title = "Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children",
abstract = "Based on data from the Longitudinal Study of Australian Children linked with pharmacy dispensing data from the Australian Government’s Pharmaceutical Benefits Scheme, we calculated the 1-year prevalence of psychotropic medicine supply in children and adolescents with Autism Spectrum Disorder (ASD) as reported by parents in 2014. The majority of children and adolescents with ASD in Australia were not treated with psychotropic medicine. One-third had claims for at least one psychotropic medication, most commonly medications for attention-deficit/hyperactivity disorder (ADHD), and antidepressants. Antipsychotics were supplied to less than one in twenty children and approximately one in ten adolescents. In line with findings from North America, psychotropic medicine was more often supplied to children and adolescents with ASD and comorbid ADHD.",
keywords = "Australia, Autism, Autism spectrum disorder, Drug utilization, Psychotropic drugs",
author = "Lotte Rasmussen and Nicole Pratt and Elizabeth Roughead and Anna Moffat",
year = "2019",
month = "1",
doi = "10.1007/s10803-018-3718-3",
language = "English",
volume = "49",
pages = "227–235",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer",
number = "1",

}

Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder : A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children. / Rasmussen, Lotte; Pratt, Nicole; Roughead, Elizabeth; Moffat, Anna.

I: Journal of Autism and Developmental Disorders, Bind 49, Nr. 1, 01.2019, s. 227–235.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder

T2 - A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children

AU - Rasmussen, Lotte

AU - Pratt, Nicole

AU - Roughead, Elizabeth

AU - Moffat, Anna

PY - 2019/1

Y1 - 2019/1

N2 - Based on data from the Longitudinal Study of Australian Children linked with pharmacy dispensing data from the Australian Government’s Pharmaceutical Benefits Scheme, we calculated the 1-year prevalence of psychotropic medicine supply in children and adolescents with Autism Spectrum Disorder (ASD) as reported by parents in 2014. The majority of children and adolescents with ASD in Australia were not treated with psychotropic medicine. One-third had claims for at least one psychotropic medication, most commonly medications for attention-deficit/hyperactivity disorder (ADHD), and antidepressants. Antipsychotics were supplied to less than one in twenty children and approximately one in ten adolescents. In line with findings from North America, psychotropic medicine was more often supplied to children and adolescents with ASD and comorbid ADHD.

AB - Based on data from the Longitudinal Study of Australian Children linked with pharmacy dispensing data from the Australian Government’s Pharmaceutical Benefits Scheme, we calculated the 1-year prevalence of psychotropic medicine supply in children and adolescents with Autism Spectrum Disorder (ASD) as reported by parents in 2014. The majority of children and adolescents with ASD in Australia were not treated with psychotropic medicine. One-third had claims for at least one psychotropic medication, most commonly medications for attention-deficit/hyperactivity disorder (ADHD), and antidepressants. Antipsychotics were supplied to less than one in twenty children and approximately one in ten adolescents. In line with findings from North America, psychotropic medicine was more often supplied to children and adolescents with ASD and comorbid ADHD.

KW - Australia

KW - Autism

KW - Autism spectrum disorder

KW - Drug utilization

KW - Psychotropic drugs

U2 - 10.1007/s10803-018-3718-3

DO - 10.1007/s10803-018-3718-3

M3 - Journal article

C2 - 30136113

AN - SCOPUS:85052664432

VL - 49

SP - 227

EP - 235

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 1

ER -